The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
Recent advances (2015–2016) in anticancer hybrids
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bioavailability of curcumin: Problems and promises
Anand, P., Kunnumakkara, A. B., Newman, R. A., & Aggarwal, B. B. (2007) · Molecular Pharmaceutics · doi:10.1021/mp700113r · Cited by 5,543
Multidrug resistance in cancer: role of ATP–dependent transporters
Gottesman, M. M., Fojo, T., & Bates, S. E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc706 · Cited by 5,536
5-Fluorouracil: mechanisms of action and clinical strategies
Longley, D. B., Harkin, D. P., & Johnston, P. G. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1074 · Cited by 5,332
Monitoring Drug Target Engagement in Cells and Tissues Using the Cellular Thermal Shift Assay
Molina, D. M., Jafari, R., Ignatushchenko, M., Seki, T., Larsson, E. A., Dan, C., Sreekumar, L., Cao, Y., & Nordlund, P. (2013) · Science · doi:10.1126/science.1233606 · Cited by 2,261
Discovery and development of sorafenib: a multikinase inhibitor for treating cancer
Wilhelm, S., Carter, C., Lynch, M., Lowinger, T., Dumas, J., Smith, R. A., Schwartz, B., Simantov, R., & Kelley, S. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2130 · Cited by 1,829
Motzer, R. J., Michaelson, M. D., Redman, B. G., Hudes, G. R., Wilding, G., Figlin, R. A., Ginsberg, M. S., Kim, S. T., Baum, C. M., DePrimo, S. E., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.2574 · Cited by 1,634
Promoting apoptosis as a strategy for cancer drug discovery
Fesik, S. W. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1736 · Cited by 1,098
Cui, J. J., Tran-Dubé, M., Shen, H., Nambu, M., Kung, P.-P., Pairish, M., Jia, L., Meng, J., Funk, L., Botrous, I., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm2007613 · Cited by 932
The Effect of Prescribed Daily Dose Frequency on Patient Medication Compliance
Eisen, S. A. (1990) · Archives of Internal Medicine · doi:10.1001/archinte.150.9.1881 · Cited by 817
Recent developments in biological activities of chalcones: A mini review
Singh, P., Anand, A., & Kumar, V. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.08.033 · Cited by 710
Self-citationPotential Mechanism for Sustained Antiretroviral Efficacy of AZT-3TC Combination Therapy
Larder, B. A., Kemp, S. D., & Harrigan, P. R. (1995) · Science · doi:10.1126/science.7542804 · Cited by 623
Fibroblast growth factors and their receptors in cancer
Wesche, J., Haglund, K., & Haugsten, E. M. (2011) · Biochemical Journal · doi:10.1042/bj20101603 · Cited by 534
Clinical, Cellular, and Molecular Aspects of Cancer Invasion
Mareel, M., & Leroy, A. (2003) · Physiological Reviews · doi:10.1152/physrev.00024.2002 · Cited by 524
Marsilje, T. H., Pei, W., Chen, B., Lu, W., Uno, T., Jin, Y., Jiang, T., Kim, S., Li, N., Warmuth, M., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400402q · Cited by 418
Sunitinib: A VEGF and PDGF receptor protein kinase and angiogenesis inhibitor
Roskoski, R. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.02.156 · Cited by 412
Harris, P. A., Boloor, A., Cheung, M., Kumar, R., Crosby, R. M., Davis-Ward, R. G., Epperly, A. H., Hinkle, K. W., Hunter, R. N., Johnson, J. H., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800566m · Cited by 352
Burgos‐Morón, E., Calderón‐Montaño, J. M., Salvador, J., Robles, A., & López‐Lázaro, M. (2010) · International Journal of Cancer · doi:10.1002/ijc.24967 · Cited by 336
Prenen, H., Cools, J., Mentens, N., Folens, C., Sciot, R., Schöffski, P., Van Oosterom, A., Marynen, P., & Debiec-Rychter, M. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2275 · Cited by 274
Roth, G. J., Heckel, A., Colbatzky, F., Handschuh, S., Kley, J., Lehmann-Lintz, T., Lotz, R., Tontsch-Grunt, U., Walter, R., & Hilberg, F. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900431g · Cited by 237
Reddy, T. S., Kulhari, H., Reddy, V. G., Bansal, V., Kamal, A., & Shukla, R. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.07.031 · Cited by 194
Therapeutic Protein Kinase Inhibitors
Grant, S. K. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8539-7 · Cited by 194
1,2,3-Triazole tethered β-lactam-Chalcone bifunctional hybrids: Synthesis and anticancer evaluation
Singh, P., Raj, R., Kumar, V., Mahajan, M. P., Bedi, P. M. S., Kaur, T., & Saxena, A. K. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.10.033 · Cited by 177
Self-citationKibria, G., Hatakeyama, H., & Harashima, H. (2014) · Archives of Pharmacal Research · doi:10.1007/s12272-013-0276-2 · Cited by 171
Chemopreventive potential of curcumin in prostate cancer
Teiten, M.-H., Gaascht, F., Eifes, S., Dicato, M. A., & Diederich, M. F. (2009) · Genes & Nutrition · doi:10.1007/s12263-009-0152-3 · Cited by 167
Kraljević, T. G., Harej, A., Sedić, M., Pavelić, S. K., Stepanić, V., Drenjančević, D., Talapko, J., & Raić‐Malić, S. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.08.062 · Cited by 147
Harnessing the fruits of nature for the development of multi-targeted cancer therapeutics
Sarkar, F. H., & Li, Y. (2009) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2009.07.001 · Cited by 146
Synthesis of novel quinoline-2-one based chalcones of potential anti-tumor activity
Abonía, R., Insuasty, D., Castillo, J., Braulio Insuasty, O., Jairo Quiroga, P., Nogueras, M., & Cobo, J. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.08.039 · Cited by 140
Benzimidazole clubbed with triazolo-thiadiazoles and triazolo-thiadiazines: New anticancer agents
Husain, A., Rashid, M., Yar, M. S., Siddiqui, A. A., & Mishra, R. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.07.011 · Cited by 139
Novel pyrazole-5-carboxamide and pyrazole–pyrimidine derivatives: Synthesis and anticancer activity
Shi, J., Tang, W. J., qi, X. B., Li, R., & Liu, X. H. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.12.013 · Cited by 123
Curcumin Recognizes a Unique Binding Site of Tubulin
Chakraborti, S., Das, L., Kapoor, N., Das, A. K., Dwivedi, V., Poddar, A., Chakraborti, G., Janik, M. E., Basu, G., Panda, D., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm2004046 · Cited by 112
α-Glucosidase inhibitory antihyperglycemic activity of substituted chromenone derivatives
Raju, B. C., Tiwari, A. K., Jaladi, A. K., Ali, A. Z., Agawane, S. B., Saidachary, G., & Madhusudana, K. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.10.047 · Cited by 106
Design and synthesis of novel 1,2,3-triazole–pyrimidine–urea hybrids as potential anticancer agents
Ma, L., Wang, B., Pang, L.-P., Zhang, M., Wang, S., Zheng, Y., Shao, K., Xue, D., & Liu, H. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.12.087 · Cited by 102
Cai, H., Huang, X., Xu, S., Shen, H., Zhang, P., Huang, Y., Jiang, J., Sun, Y., Jiang, B., Wu, X., et al. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.11.013 · Cited by 102
Singla, P., Luxami, V., & Paul, K. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.03.012 · Cited by 98
Reddy, T. S., Kulhari, H., Reddy, V. G., Rao, A., Bansal, V., Kamal, Ä., & Shukla, R. (2015) · Organic & Biomolecular Chemistry · doi:10.1039/c5ob00842e · Cited by 94
El‐Karim, S. S. A., Anwar, M. M., Mohamed, N. A., Nasr, T., & Elseginy, S. A. (2015) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2015.08.006 · Cited by 92
Vijayaraghavalu, S., Peetla, C., Lu, S., & Labhasetwar, V. D. (2012) · Molecular Pharmaceutics · doi:10.1021/mp300281t · Cited by 85
Singla, P., Luxami, V., & Paul, K. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.03.088 · Cited by 82
Qin, H., Shang, Z., Jantan, I., Tan, O. Ü., Hussain, M. A., Sher, M., & Bukhari, S. N. A. (2015) · RSC Advances · doi:10.1039/c5ra02995c · Cited by 81
Kuntala, N., Telu, J. R., Banothu, V., Nallapati, S. B., Anireddy, J. S., & Pal, S. (2015) · MedChemComm · doi:10.1039/c5md00224a · Cited by 76
Issa, D. A. E., Habib, N. S., & Wahab, A. E. A. (2014) · MedChemComm · doi:10.1039/c4md00257a · Cited by 75
Kumar, C. P., Reddy, T. S., Mainkar, P. S., Bansal, V., Shukla, R., Chandrasekhar, S., & Hügel, H. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.12.007 · Cited by 70
Synthesis and anticancer activity of novel curcumin–quinolone hybrids
Raghavan, S., Manogaran, P., Narasimha, K. K. G., Kuppusami, B. K., Mariyappan, P., Gopalakrishnan, A., & Venkatraman, G. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.06.068 · Cited by 69
Yan, J., Guo, Y., Wang, Y., Mao, F., Huang, L., & Li, X. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.03.030 · Cited by 67
Activity of novel quinoxaline-derived chalcones on in vitro glioma cell proliferation
Mielcke, T. R., Mascarello, A., Filippi‐Chiela, E. C., Zanin, R. F., Lenz, G., Leal, P. C., Chirardia, L. D., Yunes, R. A., Nunes, R. J., Battastini, A. M. O., et al. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.12.023 · Cited by 66
Sharma, P., Senwar, K. R., Jeengar, M. K., Reddy, T. S., Naidu, V. G. M., Kamal, Ä., & Shankaraiah, N. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.09.025 · Cited by 64
Synthesis, antimalarial activity and cytotoxic potential of new monocarbonyl analogues of curcumin
Manohar, S., Khan, S. I., Kandi, S. K., Raj, K. K., Sun, G., Yang, X., Molina, A. D. C., Ni, N., Wang, B., & Rawat, D. S. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.11.004 · Cited by 61
Multifactorial nature of tumor drug resistance.
Solyanik, G. I. (2010) · PubMed · Cited by 60
Liu, Y., Lang, Y., Patel, N. K., Ng, G., Laufer, R. S., Li, S.-W., Edwards, L. G., Forrest, B., Sampson, P. B., Fehér, M., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/jm501740a · Cited by 57
Behrenswerth, A., Volz, N., Toräng, J., Hinz, S., Bräse, S., & Müller, C. E. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.02.027 · Cited by 53
Wei, G., Luan, W., Wang, S., Cui, S., Fengran, L., Liu, Y., Liu, Y., & Cheng, M. (2014) · Organic & Biomolecular Chemistry · doi:10.1039/c4ob01605j · Cited by 53
Kumbhare, R. M., Dadmal, T. L., Ramaiah, M. J., Kishore, K., Valli, S. N. C. V. L. P., Tiwari, S. K., Appalanaidu, K., Rao, Y. K., & Bhadra, M. P. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.11.083 · Cited by 52
Ghorab, M. M., Ragab, F. A.-F., Heiba, H. I., & Soliman, A. M. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.04.009 · Cited by 51
Lv, P., Elsayed, M., Agama, K., Marchand, C., Pommier, Y. G., & Cushman, M. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00220 · Cited by 49
Marković, V. R., Debeljak, N., Stanojković, T., Kolundžija, B., Sladić, D. M., Vujčić, M. T., Janović, B. S., Tanić, N., Perović, M., Tešić, V., et al. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.10.055 · Cited by 47
Goel, R., Luxami, V., & Paul, K. (2015) · RSC Advances · doi:10.1039/c5ra00584a · Cited by 45
Sharma, A., Luxami, V., & Paul, K. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.02.036 · Cited by 43
Yu, B., Wang, S., Qi, P., Yang, D., Tang, K., & Liu, H. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.08.065 · Cited by 42
Cancer Epidemiology in the United States: Racial, Social, and Economic Factors
Sloane, D. A. (2008) · Methods in molecular biology · doi:10.1007/978-1-59745-416-2_4 · Cited by 40
Alafeefy, A. M., Ashour, A. E., Prasad, O., Sinha, L., Pathak, S. K., Alasmari, F. A., Rishi, A. K., & Abdel‐Aziz, H. A. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.12.048 · Cited by 38
Tang, Z., Wu, C.-Z., Wang, T., et al. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.04.029 · Cited by 38
Chen, J., Yan, J., Hu, J., et al. (2015) · RSC Advances · doi:10.1039/c5ra14888j · Cited by 37
Chen, Q., Yu, K. S., Zhang, X., Chen, G., Hoover, A., León, F., Wang, R., Subrahmanyam, N. B., Addo, E. M., & Harinantenaina, L. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.08.064 · Cited by 34
Synthesis and bio-evaluation of novel quinolino-stilbene derivatives as potential anticancer agents
Srivastava, V., & Lee, H. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.11.007 · Cited by 34
Vannini, F., MacKessack-Leitch, A. C., Eschbach, E. K., Chattopadhyay, M., Kodela, R., & Kashfi, K. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.08.023 · Cited by 33
Synthesis and anticancer activity of 6-heteroarylcoumarins
Galayev, O., Garazd, Y., Garazd, M. M., & Lesyk, R. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.10.021 · Cited by 33
Synthesis of 2-anilinopyridyl–triazole conjugates as antimitotic agents
Kamal, Ä., Rao, A., Vishnuvardhan, M. V. P. S., Reddy, T. S., Swapna, K., Bagul, C., Reddy, N. V. S., & Srinivasulu, V. (2015) · Organic & Biomolecular Chemistry · doi:10.1039/c5ob00232j · Cited by 32
Xu, S., Wang, G., Lin, Y., Zhang, Y., Pei, L., Yao, H., Hu, M. Y., Qiu, Y., Huang, Z., Zhang, Y., et al. (2016) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2016.04.068 · Cited by 29
Mudududdla, R., Guru, S. K., Wani, A., Sharma, S., Joshi, P., Vishwakarma, R. A., Kumar, A., Bhushan, S., & Bharate, S. B. (2015) · Organic & Biomolecular Chemistry · doi:10.1039/c5ob00233h · Cited by 28
Wang, R., Zhang, X., Chen, C., et al. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.01.017 · Cited by 26
Chalcone-based inhibitors against hypoxia-inducible factor 1—Structure activity relationship studies
Srinivasan, B., Johnson, T. E., & Xing, C. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.10.063 · Cited by 25
Zhou, W., Huang, A., Zhang, Y., Lin, Q., Guo, W., You, Z., Yi, Z., Liu, M., & Chen, Y. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.04.027 · Cited by 25
Qiao, F., Yin, Y., Shen, Y., Wang, S., Sha, S., Wu, X., Lu, A., Xu, C., Zhang, W., & Zhu, H. (2015) · RSC Advances · doi:10.1039/c4ra11780h · Cited by 25
Ren, Y.-J., Wang, Z., Zhang, X., Qiu, H., Wang, P., Gong, H., Jiang, A.-Q., & Zhu, H. (2015) · RSC Advances · doi:10.1039/c4ra10606g · Cited by 14
Synthesis and in vitro antiproliferative activity of novel pyrazolo[3,4- d ]pyrimidine derivatives
Samir, N., Serya, R. A. T., Esmat, A., Tolba, M. F., Ismail, N. S. M., & Abouzid, K. A. M. (2015) · MedChemComm · doi:10.1039/c5md00127g · Cited by 12
Cited by
A Review on Recent Advances in Nitrogen-Containing Molecules and Their Biological Applications
Kerru, N., Gummidi, L., Maddila, S., Gangu, K. K., & Jonnalagadda, S. B. (2020) · Molecules · doi:10.3390/molecules25081909 · Cited by 1,716
Self-citationRecent advances in the pharmacological diversification of quinazoline/quinazolinone hybrids
Auti, P. S., George, G., & Paul, A. T. (2020) · RSC Advances · doi:10.1039/d0ra06642g · Cited by 324
Development of Dual Inhibitors Targeting Epidermal Growth Factor Receptor in Cancer Therapy
Tan, L., Zhang, J., Wang, Y., Wang, X., Wang, Y., Zhang, Z., Shuai, W., Wang, G., Chen, J., Wang, C., et al. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01714 · Cited by 88
Anticancer Drug Conjugates Incorporating Estrogen Receptor Ligands
Zlotos, D. P., Kronenberger, T., & Laufer, S. A. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics15010067 · Cited by 9
“Anticancer drug conjugates (hybrid anticancer agents) are an emerging approach to overcome drawbacks of current anticancer treatment, such as insufficient potency and efficacy, high toxicity, and development of resistance [1,2].”
Background
Metadata
- Authors
- Kerru, N., Singh, P., Koorbanally, N., Raj, R., & Kumar, V.
- Venue
- European Journal of Medicinal Chemistry
- Publisher
- Elsevier BV
- Published
- 2017-12
- Volume
- 142
- Pages
- 179-212
- ISSN
- 0223-5234 (ISSN-L)
- OpenAlex
- W2736521173
- Cited by
- 295
- References
- 75
- FWCI
- 9.51
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.